Novartis picks up initial 26% equity in ophthalmics manufacturer Alcon from Nestlé.
Alcon second-quarter profit rises 26 pct.
Related posts:
- Novartis Still On Track to Buy Majority In Alcon
- From Allergan To Advanced Medical Optics To Abbott In 7 Years
- Homecare Sales Mid 2010 Reflect Renewed Growth – From Wheelchairs To Sleep Apnea Products
- (More Unbridled Capitalism As) Patients Battle For Drugs In The UK
- After Merits, Shoprider – It Is Now Kymco


